Dermata Therapeutics, Inc. (DRMA) Form S-3/A — May 22, 2026

$DRMAForm S-3/AFiled May 22, 2026, 5:15 PM ET0001493152-26-025073Original filing

Dermata Therapeutics, Inc. filed Amendment No. 1 to its Form S-3 registration statement to register up to $100 million of common stock, preferred stock, warrants, debt securities, and units. The filing indicates that securities may be offered from time to time, with the aggregate public offering price not exceeding the registered amount.

Key figures

Shares Outstanding: 4022143
Public Float: $3,955,179.64
Net Loss FY 2025: $7.6 million
Net Loss Q1 2026: $1.8 million
Warrant Price May21: $0.0139
Accumulated Deficit: $75.1 million
Sec Registration Fee: $809.54
Atm Net Proceeds Jan2026: $2.0 million
Common Stock Price May21: $1.24
Aggregate Offering Price: $100,000,000
Gross Proceeds Since Inception: $84.1 million

Price after filing

1 day: 0.0%7 days: +8.9%30 days: -5.6%

Close on the filing date to close N calendar days later (from $1.24). Historical, not a forecast.

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.